Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease
Mycophenolic acid (MPA), the active drug moiety of mycophenolate, is a potent immunosuppressant agent, which is increasingly being used in the treatment of patients with various autoimmune diseases. An understanding of the pharmacokinetics and pharmacodynamics of mycophenolate in this population sho...
Main Authors: | Abd. Rahman, Nurul Azrin, Tett, Susan E., Staatz, Christian E. |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer International Publishing AG
2013
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/30553/ http://irep.iium.edu.my/30553/ http://irep.iium.edu.my/30553/ http://irep.iium.edu.my/30553/1/Azrin_AbdRahman_2013.pdf |
Similar Items
-
How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?
by: Abd. Rahman, Nurul Azrin, et al.
Published: (2014) -
Applying pharmacokinetic/pharmacodynamic
principles in critically ill patients: optimizing
efficacy and reducing resistance development
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2015) -
Pharmacokinetic/pharmacodynamics-optimized antimicrobial therapy in patients with hospital-acquired pneumonia/ventilator-associated pneumonia
by: Sulaiman, Helmi, et al.
Published: (2017) -
Plasma & subcutaneous tissue pharmacokinetics of piperacillin in a large cohort of critically ill patients with sepsis
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2014) -
Pharmacokinetic and sub-chronic toxicity study of a fixed dose combination and a sustained release tablet
by: Chatterjee, Bappaditya, et al.
Published: (2017)